Sandler Capital Management Procept Bio Robotics Corp Transaction History
Sandler Capital Management
- $870 Million
- Q4 2024
A detailed history of Sandler Capital Management transactions in Procept Bio Robotics Corp stock. As of the latest transaction made, Sandler Capital Management holds 52,223 shares of PRCT stock, worth $3.18 Million. This represents 0.48% of its overall portfolio holdings.
Number of Shares
52,223Holding current value
$3.18 Million% of portfolio
0.48%Shares
1 transactions
Others Institutions Holding PRCT
# of Institutions
294Shares Held
40.1MCall Options Held
196KPut Options Held
141K-
Vanguard Group Inc Valley Forge, PA5.14MShares$313 Million0.01% of portfolio
-
Black Rock Inc. New York, NY3.49MShares$212 Million0.0% of portfolio
-
Alliancebernstein L.P. New York, NY1.75MShares$107 Million0.05% of portfolio
-
Loomis Sayles & CO L P1.21MShares$73.5 Million0.12% of portfolio
-
State Street Corp Boston, MA1.19MShares$72.4 Million0.0% of portfolio
About PROCEPT BioRobotics Corp
- Ticker PRCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 44,592,300
- Market Cap $2.72B
- Description
- PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally-invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). The company also designs Aqu...